Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E DOWLING

Showing results (381-390 of 406) with videos related to

Pageof 41
Sort By:
ACS Medicinal Chemistry Letters|March 18, 2016
Potent and Selective CK2 Kinase Inhibitors with Effects on Wnt Pathway Signaling in VivoJames E Dowling, Marat Alimzhanov, Larry Bao, et al.
ACS Medicinal Chemistry Letters|December 21, 2016
Optimization of Highly Kinase Selective Bis-anilino Pyrimidine PAK1 InhibitorsWilliam McCoull, Edward J Hennessy, Kevin Blades, et al.
Journal of Medicinal Chemistry|December 3, 2014
Discovery of potent KIFC1 inhibitors using a method of integrated high-throughput synthesis and screeningBin Yang, Michelle L Lamb, Tao Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|July 30, 2020
Identification of a novel series of azabenzimidazole-derived inhibitors of spleen tyrosine kinaseSameer P Kawatkar, Bernard Barlaam, Paul Kemmitt, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Structure and Property Based Design of Pyrazolo[1,5-a]pyrimidine Inhibitors of CK2 Kinase with Activity in VivoJames E Dowling, Marat Alimzhanov, Larry Bao, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2012
Discovery of novel benzylidene-1,3-thiazolidine-2,4-diones as potent and selective inhibitors of the PIM-1, PIM-2, and PIM-3 protein kinasesLes A Dakin, Michael H Block, Huawei Chen, et al.
Bioorganic & Medicinal Chemistry Letters|March 22, 2018
Discovery of 2,6-disubstituted pyrazine derivatives as inhibitors of CK2 and PIM kinasesLakshmaiah Gingipalli, Michael H Block, Larry Bao, et al.
Chemmedchem|April 4, 2017
Target Deconvolution Efforts on Wnt Pathway Screen Reveal Dual Modulation of Oxidative Phosphorylation and SERCA2Matias Casás-Selves, Andrew X Zhang, James E Dowling, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Potent and Selective Inhibitors of CK2 Kinase Identified through Structure-Guided HybridizationJames E Dowling, Claudio Chuaqui, Timothy W Pontz, et al.
Nature Communications|August 28, 2020
Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patientsS G P Funnell, W E Dowling, C Muñoz-Fontela, et al.
Pageof 41

Showing results (381-390 of 406) with videos related to

Sort By:
Pageof 41
ACS Medicinal Chemistry Letters|March 18, 2016
Potent and Selective CK2 Kinase Inhibitors with Effects on Wnt Pathway Signaling in VivoJames E Dowling, Marat Alimzhanov, Larry Bao, et al.
ACS Medicinal Chemistry Letters|December 21, 2016
Optimization of Highly Kinase Selective Bis-anilino Pyrimidine PAK1 InhibitorsWilliam McCoull, Edward J Hennessy, Kevin Blades, et al.
Journal of Medicinal Chemistry|December 3, 2014
Discovery of potent KIFC1 inhibitors using a method of integrated high-throughput synthesis and screeningBin Yang, Michelle L Lamb, Tao Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|July 30, 2020
Identification of a novel series of azabenzimidazole-derived inhibitors of spleen tyrosine kinaseSameer P Kawatkar, Bernard Barlaam, Paul Kemmitt, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Structure and Property Based Design of Pyrazolo[1,5-a]pyrimidine Inhibitors of CK2 Kinase with Activity in VivoJames E Dowling, Marat Alimzhanov, Larry Bao, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2012
Discovery of novel benzylidene-1,3-thiazolidine-2,4-diones as potent and selective inhibitors of the PIM-1, PIM-2, and PIM-3 protein kinasesLes A Dakin, Michael H Block, Huawei Chen, et al.
Bioorganic & Medicinal Chemistry Letters|March 22, 2018
Discovery of 2,6-disubstituted pyrazine derivatives as inhibitors of CK2 and PIM kinasesLakshmaiah Gingipalli, Michael H Block, Larry Bao, et al.
Chemmedchem|April 4, 2017
Target Deconvolution Efforts on Wnt Pathway Screen Reveal Dual Modulation of Oxidative Phosphorylation and SERCA2Matias Casás-Selves, Andrew X Zhang, James E Dowling, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Potent and Selective Inhibitors of CK2 Kinase Identified through Structure-Guided HybridizationJames E Dowling, Claudio Chuaqui, Timothy W Pontz, et al.
Nature Communications|August 28, 2020
Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patientsS G P Funnell, W E Dowling, C Muñoz-Fontela, et al.
Pageof 41